To evaluate the impact of suppressing inositol 1,4,5-trisphosphate (InsP 3 ) in plants, tobacco (Nicotiana tabacum) cells were transformed with the human type I inositol polyphosphate 5-phosphatase (InsP 5-ptase), an enzyme which specifically hydrolyzes InsP 3 . The transgenic cell lines showed a 12-to 25-fold increase in InsP 5-ptase activity in vitro and a 60% to 80% reduction in basal InsP 3 compared with wild-type cells. Stimulation with Mas-7, a synthetic analog of the wasp venom peptide mastoparan, resulted in an approximately 2-fold increase in InsP 3 in both wild-type and transgenic cells. However, even with stimulation, InsP 3 levels in the transgenic cells did not reach wild-type basal values, suggesting that InsP 3 signaling is compromised. Analysis of whole-cell lipids indicated that phosphatidylinositol 4,5-bisphosphate (PtdInsP 2 ), the lipid precursor of InsP 3 , was greatly reduced in the transgenic cells. In vitro assays of enzymes involved in PtdInsP 2 metabolism showed that the activity of the PtdInsP 2 -hydrolyzing enzyme phospholipase C was not significantly altered in the transgenic cells. In contrast, the activity of the plasma membrane PtdInsP 5 kinase was increased by approximately 3-fold in the transgenic cells. In vivo labeling studies revealed a greater incorporation of 32 P into PtdInsP 2 in the transgenic cells compared with the wild type, indicating that the rate of PtdInsP 2 synthesis was increased. These studies show that the constitutive expression of the human type I InsP 5-ptase in tobacco cells leads to an up-regulation of the phosphoinositide pathway and highlight the importance of PtdInsP 2 synthesis as a regulatory step in this system.
In plants the phosphoinositide (PI) pathway has been implicated in the transduction of signals after a multitude of stimuli (Drøbak, 1992; Munnik et al., 1998a; Stevenson et al., 2000) . Upon stimulation, the membrane-associated phospholipid, phosphatidylinositol 4,5-bisphosphate (PtdInsP 2 ), is hydrolyzed by phospholipase C (PLC) to produce inositol 1,4,5-trisphosphate (InsP 3 ) and diacylglycerol (Berridge, 1993) . InsP 3 can act as a soluble second messenger to mediate the release of Ca 2ϩ from intracellular stores, such as the vacuole (for review, see Sanders et al., 1999) . Furthermore, because InsP 3 can travel between cells through plasmodesmatal connections (Tucker and Boss, 1996) , it fulfills the requirements for a rapidly diffusible signaling molecule in both intraand intercellular signal propagation.
Rapid transient increases in InsP 3 have been demonstrated in various plant tissues in response to environmental stimuli and chemical effectors, including hyperosmotic stress (Srivastava et al., 1989; Heilmann et al., 1999 Heilmann et al., , 2001 DeWald et al., 2001; Takahashi et al., 2001) , salinity (Drøbak and Watkins, 2000) , cold shock (Smolenska-Sym and Kacperska, 1996) , oligogalacturonide elicitors (Legendre et al., 1993) , fusicoccin (Aducci and Marra, 1990) , mastoparan (Legendre et al., 1993; Drøbak and Watkins, 1994; Cho et al., 1995; Franklin-Tong et al., 1996) , abscisic acid (ABA; Lee et al., 1996) , and gravity (Perera et al., 1999 (Perera et al., , 2001 .
In addition to a second messenger role for InsP 3 in reversible turgor-driven processes, such as regulation of stomatal aperture and cellular osmotic homeostasis, evidence is accumulating that long-term InsP 3 changes may be involved in directing differential plant growth (for review, see Stevenson et al., 2000) . Studies of tip-growing cells such as pollen tubes (Franklin-Tong et al., 1996; Kost et al., 1999) , and the graviresponsive pulvinal cells of cereal grasses (Perera et al., 1999 (Perera et al., , 2001 ) have shown that long-term increases in both InsP 3 and PtdInsP 2 synthesis are involved in the regulation of cell elongation.
For InsP 3 to function as a second messenger, the duration of an InsP 3 signal must be tightly regulated and the signal rapidly degraded to affect spatially and temporally discrete responses. In animal cells, removal of InsP 3 can occur either via the phosphorylation of the D-3 position of the inositol ring by a specific Ins(1,4,5)P 3 3-kinase to form InsP 4 (Takazawa et al., 1991) or by dephosphorylation of the D-5 po-sition of the inositol ring by inositol polyphosphate 5-phosphatase (InsP 5-ptase) to form InsP 2 .
The mammalian InsP 5-ptases are a family of enzymes classified into four types based on their substrate specificity (Mitchell et al., 1996; Jefferson et al., 1997; Majerus et al., 1999) . The type I InsP 5-ptase exclusively hydrolyzes the water-soluble inositol polyphosphates, Ins(1,4,5)P 3 and Ins(1,3,4,5)P 4 , unlike the type II and III InsP 5-ptases, which can hydrolyze both the water soluble and the lipid inositol polyphosphates (Laxminarayan et al., 1993 (Laxminarayan et al., , 1994 Matzaris et al., 1994) and the type IV enzymes that only hydrolyze the lipid PtdIns(3,4,5)P 3 (Majerus et al., 1999) . The mammalian type I InsP 5-ptase, which is encoded by a single gene (Mitchell et al., 1996; Erneux et al., 1998) , plays a major role in the termination of InsP 3 signals in animal cells and overand underproduction of this enzyme was shown to profoundly affect InsP 3 -mediated Ca 2ϩ signaling (De Smedt et al., 1997; Speed et al., 1996 Speed et al., , 1999 Speed and Mitchell, 2000) .
At present, the mechanisms of InsP 3 hydrolysis in plants are not well understood. There has been no biochemical evidence of InsP 3 3-kinases in plants (Phillippy, 1999; Brearley and Hanke, 2000) . However, there are many reports of InsP phosphatases, suggesting that InsP 3 degradation in plants is primarily via dephosphorylation. Early biochemical studies (Joseph et al., 1989; Drøbak et al., 1991; Martinoia et al., 1993) have implicated the involvement of both an InsP 5-ptase and InsP 1-ptase in InsP 3 hydrolysis. The principal route of InsP 3 inactivation may involve either an InsP 1-ptase or an InsP 5-ptase depending on the specific plant system or developmental stage (Brearley et al., 1997; DePass et al., 2001) . At the molecular level, the Arabidopsis genome contains 15 putative InsP 5-ptase genes, which can be categorized into three groups based on size and sequence (Berdy et al., 2001) . Our current understanding of the function and localization of the plant InsP 5-ptases is limited. Two of the Arabidopsis InsP 5-ptase genes, At5PTase1 (Berdy et al., 2001 ) and AtIP5PII (Sanchez and Chua, 2001) , have been characterized and shown to possess InsP 3 -hydrolyzing activity in vitro and in vivo. Both At5PT1 and AtIP5PII share significantly greater sequence similarity over their catalytic domains with the animal type II InsP 5-ptase enzymes (42% and 57%, respectively) than with the animal type I enzyme (approximately 19%). Based on sequence analysis, there does not appear to be a homolog of the human type I InsP 5-ptase in the Arabidopsis genome.
Although changes in InsP 3 may be an essential component of the PI signaling pathway, it has been difficult to link these changes with a specific physiological response. Pharmacological agents such as the aminosteroid PLC inhibitor U73122 have been used quite effectively to interfere with InsP 3 production and thereby block a downstream response in certain plant systems (Staxen et al., 1999; Perera et al., 2001; Takahashi et al., 2001 ). However, this approach has its limitations, primarily due to problems with uptake and delivery of compounds into intact plant tissues, and the potential nonspecific side effects of the inhibitor treatments (Cho et al., 1995; Munnik et al., 1998a) . A molecular approach to reduce or eliminate InsP 3 would have broader applicability and the InsP 5-ptase enzyme is an obvious target for manipulation.
Recently, Sanchez and Chua (2001) have examined the downstream consequences of altering InsP 3 in ABA-regulated processes by generating transgenic plants expressing an Arabidopsis InsP 5-ptase gene (AtIP5PII) under the control of an inducible promoter. A 4-to 5-fold increase in InsP 5-ptase activity was detected in the transgenic plants after approximately 12 h of induction, and transgenic lines exhibited decreased sensitivity to the inhibitory effects of ABA on seed germination and growth, seen in wild-type plants. Expression of ABA-responsive genes after 4 h of ABA treatment was also attenuated in the transgenic plants.
The goal of our work was to study the effects of constitutively lowering cellular InsP 3 on PI signaling and metabolism in plant cells. The human type I InsP 5-ptase was selected for this study because it has an approximately two orders of magnitude higher specific activity for Ins(1,4,5)P 3 hydrolysis than the plant InsP 5-ptase enzymes characterized to date.
Here, we report that the human type I InsP 5-ptase is expressed in tobacco (Nicotiana tabacum) suspension cells and that the protein is active. The expression of InsP 5-ptase in tobacco cells leads to a drastic reduction in the basal levels of InsP 3 and in an attenuation of stimulus-induced InsP 3 changes. Significantly, the constitutive expression of InsP 5-ptase affected the upstream components of the PI pathway, resulting in increased PtdInsP 5 kinase activity and PtdInsP 2 biosynthesis.
RESULTS

Expression of the Type I InsP 5-ptase Gene in Transgenic Tobacco Cells
Tobacco (NT1) cells in suspension culture were transformed with the 35S promoter::InsP 5-ptase construct shown in Figure 1A . Of 15 independent transgenic microcalli tested for the presence of the InsP 5-ptase protein, significant protein expression was detected in 11 lines (data not shown). Three tobacco cell lines transformed with the InsP 5-ptase (I2-2, I2-8, and I2-11) and two control lines transformed with the 35S promoter-containing binary vector alone (C-3 and C-5) were chosen for further analysis. To establish whether the heterologous gene product was correctly synthesized in the tobacco cells, protein extracts were tested for the presence of InsP 5-ptase protein. Consistent with the expression of InsP 5-ptase transcripts described above, InsP 5-ptase protein could be detected in lines transformed with the InsP 5-ptase gene (I2-2, I2-8, and I2-11), but not in wild-type cells or lines transformed with the binary vector alone (C-3 and C-5). A western blot of protein extracts prepared from 4-d-old tobacco cell cultures, incubated with antiserum recognizing the His tag (Qiagen, Valencia, CA), is shown in Figure 1C . The antiserum reacted with a polypeptide of 45 kD, present only in the InsP 5-ptase cell lines (I2-2, I2-8, and I2-11) and not in wild-type or vector control (C-3 and C-5) tobacco lines. The size of the protein (approximately 45 kD) detected in the NT1 cells is identical to that of the active recombinant InsP 5-ptase protein produced in a bacterial overexpression system (pQE31), suggesting that the InsP 5-ptase gene is correctly translated in the tobacco cells.
InsP 5-ptase Expression Does Not Affect Cell Growth or Overall Cell Morphology
To determine whether InsP 5-ptase transgene expression had adverse effects on the transformed tobacco cells, cell growth, viability, and morphology were monitored over the culture cycle. Figure 2A illustrates the growth of wild-type, vector control, and InsP 5-ptase lines over a 7-d culture period. Upon transfer to fresh media, the tobacco cells typically exhibited a 2-d lag period followed by a period of exponential growth between d 3 and 6 of culture. As seen in Figure 2A , there were no significant differences in the growth rates of the wild-type and transformed cell lines over the culture cycle. Between d 6 and 7 of the culture cycle, the InsP 5-ptase cell line I2-8 showed a slight reduction in growth compared with the wild type. The growth curve of the other InsP 5-ptase line I2-2 was very similar to that of the wild-type culture.
Cell morphology and viability were examined microscopically on d 2, 4, and 6 of the culture cycle. overall morphology of the InsP 5-ptase lines as observed by light microscopy was not altered compared with the wild type over the culture period. Cell viability, monitored at d 2, 4, and 6 of the culture cycle, was found to be uniformly high in all of the cell lines (Ͼ90%). All subsequent experiments were conducted with cells from d 4 of the culture cycle (early exponential phase). Care was taken to perform experiments with cells exhibiting similar growth rates (6-7 g fresh weight of 50 mL Ϫ1 of culture at d 4).
Increased InsP 5-ptase Enzyme Activity in Transgenic Tobacco Cells Results in Reduced Basal InsP 3 Levels
To determine whether the InsP 5-ptase protein produced in the transgenic lines was catalytically active, the InsP 3 -hydrolyzing activity of lysates from tobacco cells transformed with the InsP 5-ptase was compared with that of lysates from wild-type and vector control cells. Protein lysates (separated into microsomal and soluble fractions) prepared from 4-d-old cells were incubated for 10 min with commercially available InsP 3 . After incubation, the InsP 3 content in the samples was measured. After 10 min of incubation, only approximately 1% of the total InsP 3 was hydrolyzed by fractions from wild-type and vector control lines, signifying low endogenous InsP 5-ptase activity (Fig. 3A) . The increase in InsP 5-ptase activity in the microsomal fractions of the transgenic tobacco cell lines maybe due to the fact that the mammalian type I InsP 5-ptase contains a C terminal isoprenylation site (CAAX), which is thought to be important for membrane association. In animal cells, the enzyme is found in both the cytosolic and particulate fractions. Deletion or mutation of the Cys residue in the putative isoprenylation site of the mammalian InsP 5-ptase results in a predominantly cytosolic localization (De Smedt et al., 1996) . Because isoprenylation motifs are conserved between plants and animals (Randall and Crowell, 1999) it is likely that the transgene product shows a similar subcellular distribution in the tobacco cells as in mammalian cells.
To determine whether the increased InsP 5-ptase activity affected the endogenous levels of InsP 3 in the transgenic cell lines in vivo, InsP 3 levels were measured in wild-type, vector control, and InsP 5-ptase lines at d 4 of the culture cycle. As seen in Figure 3B , both wild type and the vector control line (C-5) exhibited similar levels of InsP 3 (150-200 pmol g Ϫ1 fresh weight), whereas the three InsP 5-ptase lines (I2-2, I2-8, and I2-11) showed a 60% to 80% reduction in the levels of endogenous InsP 3 (20-60 pmol g Ϫ1 fresh weight). Reductions in basal InsP 3 levels of the InsP 5-ptase lines compared with the wild type and vector control were also observed at d 2 and 6 of the culture cycle (data not shown), indicating that the ectopically expressed InsP 5-ptase was active throughout the culture cycle.
Expression of InsP 5-ptase in Transgenic Tobacco Cells Attenuates InsP 3 Changes in Response to Mastoparan Treatment
To determine whether expression of the InsP 5-ptase would impair the ability of the transgenic tobacco cells to generate InsP 3 signals upon stimulation, wild-type cells and the transgenic line I2-8 were treated with a stimulus known to activate PLC and increase InsP 3 levels in plant cells. Treatment with mastoparan, or its synthetic analog Mas-7, has been shown to increase InsP 3 levels rapidly and transiently in suspension-cultured carrot (Daucus carota) and soybean (Glycine max) cells (Legendre et al., 1993; Drøbak and Watkins, 1994; Cho et al., 1995) and in the green algae Chlamydomonas reinhardtii and Chlamydomonas moewusii (Quarmby et al., 1992; Munnik et al., 1998b) . Application of mastoparan (in the range of 1-25 m) resulted in a concentrationdependent increase in InsP 3 levels with an approximately 4-to 5-fold increase in InsP 3 at 25 m ( Legendre et al., 1993; Drøbak and Watkins, 1994) . Both mastoparan and its synthetic analog Mas-7 have been shown to induce Ca 2ϩ influx into animal (Suh et al., 1996) and plant cells (Franklin-Tong et al., 1996; Tucker and Boss, 1996; Takahashi et al., 1998) ; however, the exact mechanism of action of mastoparan in plant cells is not known.
Wild-type and InsP 5-ptase-expressing cells (I2-8) were treated with 5 m Mas-7 or the inactive analog Mas-17, and InsP 3 levels were measured over the first few minutes. Within 1 min of treatment, there was a rapid, transient, 2-to 3-fold increase in InsP 3 in the wild-type cells, consistent with the previous reports from carrot and soybean cells (Fig. 4) . No changes in InsP 3 were detected in response to treatment with the ) from transformed and wild-type tobacco cells were incubated for 10 min at room temperature with commercial InsP 3 . Relative InsP 5-ptase activity was plotted as the percentage of InsP 3 hydrolyzed by each fraction compared with the wild-type control. The data are the averages of three independent experiments assayed in duplicate. The variation between experiments is Ͻ5%. Sample I2-11 was only assayed as a total protein extract. B, InsP 3 levels of wild-type and transformed cells from d 4 of the culture cycle were measured as described in "Materials and Methods." Data plotted are the average of four independent experiments assayed in duplicate.
inactive analog Mas-17. The InsP 5-ptase expressing line I2-8 also showed an approximately 2-fold increase in InsP 3 over basal levels at 1 min after treatment with 5 m Mas-7. However, even after stimulation, the levels of InsP 3 in the transgenic cells did not reach the wild-type basal levels and the transient increase in InsP 3 with Mas-7 treatment was greatly attenuated in cells expressing the InsP 5-ptase.
Expression of InsP 5-ptase in Transgenic Tobacco Cells Affects Upstream PI Metabolism
To determine whether the reduction in basal InsP 3 levels in the transgenic cell lines had an impact on the levels of PtdInsP 2 (the lipid precursor of InsP 3 ), total cellular PtdInsP 2 levels were measured. Figure 5A shows that the wild-type and vector control cell lines contained comparable amounts of PtdInsP 2 , based on mass measurements. In contrast, there was an approximately 70% reduction in PtdInsP 2 in cells expressing the InsP 5-ptase. These data suggest that the increased hydrolysis of InsP 3 had a direct effect on PI metabolism. We also examined the levels of inositol phospholipids by labeling cells in vivo with [ 3 H] inositol (Table I) . After 24 h of labeling, there was a small but reproducible reduction in the levels of [ 3 H] PtdInsP 2 and [ 3 H] PtdInsP in the transgenic lines compared with the wild type. Although it is more difficult to assess total lipids by in vivo labeling, these results are consistent with the reduction in whole-cell PtdInsP 2 determined by mass measurements.
The decrease in whole-cell PtdInsP 2 could have resulted from decreased synthesis or increased flux through the PI pathway. To investigate the potential effects of the transgene expression on PtdInsP 2 biosynthesis, the specific activity of PtdInsP 5 kinase (the enzyme responsible for phosphorylating PtdInsP to PtdInsP 2 ) was measured in both microsomes and plasma membrane-enriched fractions isolated by two-phase partitioning from wild-type, vector control, and InsP 5-ptase-expressing lines. Membrane fractions were incubated with [␥-32 P] ATP and excess lipid substrate, PtdIns4P. Lipids were extracted and separated by TLC and the radiolabeled lipid products analyzed with an imaging scanner (Bioscan, Washington, DC). The specific PtdInsP 5 kinase activity in microsomes from all of the transformed lines including the vector control increased slightly (30%-50%) compared with the wild type. In contrast, the specific PtdInsP 5 kinase activity in plasma membranes of tobacco cells expressing InsP 5-ptase increased approximately 3-fold compared with the wild type and vector control line (Fig. 5B) . These results show that although the total amount of PtdInsP 2 was reduced, the ability of the plasma membranes to synthesize PtdInsP 2 had increased in the transgenic cell lines.
We also investigated the possibility that the plasma membrane PI-PLC activity might be increased in the transgenic lines to compensate for the increased InsP 3 hydrolysis. As seen in Figure 5B , the plasma membrane PLC activity only increased approximately 15% to 20% in the InsP 5-ptase lines, suggesting that although the rate of InsP 3 hydrolysis had increased, PLC activity was not significantly affected.
To determine whether increasing InsP 5-ptase activity resulted in an increased flux through the PI pathway, the rate of PtdInsP 2 biosynthesis was measured in vivo.
32 Pi was added to transgenic and wildtype tobacco cells on d 4, equivalent aliquots of cells were harvested at each time point, and the lipids were extracted and separated by TLC. As seen in Figure 5C , the incorporation of 32 P into PtdInsP 2 over the first 10 min was 4-to 5-fold higher in the transgenic line compared with the wild type, consistent with an increase in PtdInsP 2 biosynthesis in the transgenic cells.
DISCUSSION
In eukaryotic cells, the intermediates of the PI pathway are maintained by the concerted action of multiple lipid kinases, lipases, and phosphatases. The membrane-associated phospholipid, PtdIns, is sequentially phosphorylated by specific lipid kinases (Drøbak et al., 1998) to form phosphatidylinositol 4-phosphate (PtdIns4P) and PtdInsP 2 , the precursor of the second messenger, InsP 3 . The sequential dephosphorylation of the membrane phospholipids and soluble inositol phosphates is brought about by specific inositol polyphosphate phosphatases (Zhang and Majerus, 1998) . We have chosen to perturb the PI pathway in tobacco cells by the constitutive expression of the human type I InsP 5-ptase, which specifically hydrolyzes InsP 3 .
The goals of this study were to: (a) generate stably transformed plant cultures expressing the heterologous gene, and (b) study the effects of constitutive expression of InsP 5-ptase on PI metabolism and InsP 3 production. We show that the human gene was expressed and active in the tobacco cells, and that the increased InsP 5-ptase activity resulted in a drastic reduction in the basal levels of InsP 3 . The transformed cells showed no visible phenotype by light microscopy and the growth rates of the transgenic cell lines under normal growth conditions did not appear to be compromised by the expression of the transgene compared with wild-type cells. However, the transgenic lines exhibited a decrease in whole-cell PtdInsP 2 and an increased rate of PtdInsP 2 biosynthesis. These data suggest that constitutively increasing InsP 3 hydrolysis leads to an increased flux through the PI pathway.
The mammalian type I InsP 5-ptase is well characterized and specifically hydrolyzes the soluble inositol phosphates, Ins(1,4,5)P 3 and Ins(1,3,4,5)P 4 (Laxminarayan et al., 1993) . Constitutive overexpression of the type I InsP 5-ptase in Chinese hamster ovary cells (CHO-K1) resulted in a 15-to 25-fold increase in InsP 5-ptase activity and approximately 75% reduction in InsP 3 levels (De Smedt et al., 1997) . Consistent with the results from animal cells, in this study, the tobacco cells constitutively expressing the human InsP 5-ptase showed a 12.5-and 25-fold increase in InsP 3 -hydrolyzing activity in soluble and microsomal fractions, respectively, and basal InsP 3 levels were reduced by 60% to 80% in the transgenic cell lines compared with wild type and vector controls.
In CHO-K1 cells, overexpression of the type I InsP 5-ptase significantly affected InsP 3 -mediated Ca 2ϩ responses to both high and low concentrations of agonist (De Smedt et al., 1997) . In the transformed CHO-K1 cells, the rapid clearing of the agonistinduced InsP 3 by the InsP 5-ptase dampened the activation of InsP 3 receptors and the generation of Ca 2ϩ oscillations (De Smedt et al., 1997). Although we have not examined responses downstream of InsP 3 in the transgenic tobacco cells expressing InsP 5-ptase, we show that production of InsP 3 with Mas-7 treatment was attenuated in these cells and that even after stimulation, InsP 3 levels remained below wildtype basal levels. With Mas-7 treatment, there was a transient increase in InsP 3 in the transgenic cells, suggesting that activation of PLC was not impaired. However, the magnitude of the InsP 3 increase was severely attenuated, consistent with the reduction in basal InsP 3 . This reduced capacity to generate InsP 3 could have a great impact on the cells' ability to respond to a stimulus. The increased rate of InsP 3 hydrolysis in the transgenic tobacco cells could have been compensated for by an up-regulation of PtdInsP 2 hydrolysis. Surprisingly, we detected only minor (15%-20%) increases in PLC activity of plasma membrane-enriched fractions from the InsP 5-ptase transgenic cell lines. In contrast to the modest increase in plasma membrane PLC activity, the specific activity of the plasma membrane PtdInsP 5 kinase from transformed tobacco cultures increased approximately 3-fold in vitro. An increased rate of PtdInsP 2 synthesis was confirmed by in vivo labeling studies. These results indicate that the plasma membrane PtdInsP 5 kinase was activated as a compensatory mechanism for the increased demand for PtdInsP 2 resulting from increased InsP 3 hydrolysis.
PtdInsP 2 is essential for the regulation of many cellular processes including cytoskeletal dynamics, vesicle trafficking, and ion transport and enzyme activity (for discussion, see Janmey, 1994 Janmey, , 1998 Toker, 1998; Stevenson et al., 2000) . It is evident that there are dynamic, functionally distinct pools of PtdInsP 2 within the cell that vary with the physiological state of the cell (Hinchliffe et al., 1998; Heilmann et al., 2001) , and PtdInsP 2 is emerging as a signaling molecule in its own right (Czech, 2000; Hinchliffe, 2000; Raucher et al., 2000) . The drastic decrease in whole-cell PtdInsP 2 in the transgenic cells (approximately 70% reduction compared with wild type) could, therefore, significantly affect global cellular function; however, no morphological differences could be detected by light microscopy between the transgenic and wild-type tobacco cells. The viability of the transgenic cells in culture was also comparable with that of the wild-type cells. These observations suggest that under the favorable growth conditions of cell culture, the transgenic cells have adjusted to a new steady-state level with lowered PIs and that morphological changes may more likely be manifested under limiting conditions or at different developmental stages in a whole-plant system.
All enzymes in a metabolic pathway can potentially contribute toward the control of flux (Thomas and Fell, 1998) . In eukaryotic cells, the steady-state levels of PtdInsP 2 in the plasma membrane pools are maintained by the activity of several enzymes involved in PtdInsP 2 turnover. PtdInsP 2 biosynthesis is dependent on the availability of the precursor lipid PtdInsP as well as on the activity of PtdInsP 5 kinase. Catabolism of PtdInsP 2 may occur either via dephosphorylation by inositol polyphosphate phosphatases or hydrolysis by PLC.
Association with cytoskeletal elements and other lipid-binding proteins can limit the availability of the lipids PtdInsP and PtdInsP 2 for enzyme action (Drøbak et al., 1994; Toker, 1998; Stevenson et al., 2000) . The availability of lipid substrates may also be controlled by the lipid transfer proteins (PITPs). In animal cells, PITP-mediated delivery of the precursor lipids to the plasma membrane for PtdInsP 2 synthesis is highly regulated (Cunningham et al., 1995; Speed and Mitchell, 2000) . Plant PITP-like proteins are biochemically distinct from their animal counterparts and may serve specialized functions (Drøbak et al., 1998; Kapranov et al., 2001) . Because the ratio of PtdInsP:PtdInsP 2 in plants is on the order of 10:1, it is unlikely that PtdInsP is a limiting factor for PtdInsP 2 biosynthesis (Stevenson et al., 2000) .
In animal cells, regulation of PtdInsP 2 biosynthesis also occurs via activation or translocation of PtdInsP 5 kinase enzymes (for review, see Hinchliffe et al., 1998) . Similarly, in plants, regulation of PtdInsP 5 kinase activity by phosphorylation (Westergren et al., 2001 ) and translocation of the enzyme (I. Heilmann and W.F. Boss, unpublished data) could contribute toward the control of PtdInsP 2 biosynthesis. Recent evidence shows that PtdInsP 5 kinase activity and PtdInsP 2 synthesis in plants change in response to stress. An up-regulation of PtdInsP 5 kinase activity was observed in maize (Zea mays) pulvini upon gravistimulation (Perera et al., 1999) , and in Galdieria sulphuraria cells in response to hyperosmotic stress (Heilmann et al., 1999 (Heilmann et al., , 2001 ). Furthermore, in G. sulphuraria cells with low levels of plasma membrane PtdInsP 2 , the increase in PtdInsP 5 kinase activity preceded InsP 3 production, suggesting that PtdInsP 5 kinase activity is highly sensitive to the demands of PtdInsP 2 turnover. Other groups have also documented increases in PtdInsP 2 biosynthesis with hyperosmotic stress DeWald et al., 2001; Takahashi et al., 2001 ) and with mastoparan treatment (Munnik et al., 1998b) , implicating the activation of the PtdInsP 5 kinases. There is also evidence that PtdInsP 5 kinase gene expression increases with salt and drought stress in Arabidopsis (Mikami et al., 1998) . These findings support the importance of PtdInsP 5 kinase in the regulation of PtdInsP 2 levels.
The mechanisms involved in PtdInsP 2 catabolism in plants are less well understood. In particular, the inositol polyphosphate phosphatases of plants that target phospholipids have not been studied in detail (Drøbak, 1992) . Information on the in vivo regulation of plant PLC enzymes is also limited. Although animal PLC enzymes comprise a large group of four families (Rhee, 2001) , which can be activated via different effectors, all the plant PLC genes characterized to date are most similar to the animal PLC ␦ family. Furthermore, the plant enzymes lack the regulatory PH domain. The PH domain of the mammalian PLC-␦1 has been shown to specifically interact with PtdInsP 2 and InsP 3 and may be involved in the translocation of the enzyme to and from the membrane (Cifuentes et al., 1994) . Plant PtdInsP 2 -hydrolyzing PLC activity is primarily associated with membrane fractions and Ca 2ϩ is required for activation (Hirayama et al., 1995; Otterhag et al., 2001 ). Both constitutive, and at least at the level of transcript, inducible, isoforms of PLC have been described in Arabidopsis (Hirayama et al., 1995 (Hirayama et al., , 1997 , supporting the idea that PLC activity increases in response to stimulation. However, increased expression of AtPLC1 did not lead to an increase in InsP 3 levels in transgenic plants (Sanchez and Chua, 2001) . Taken collectively, these observations suggest that the synthesis of PtdInsP 2 is a major factor influencing PtdInsP 2 homeostasis, which in turn is a critical determinant for InsP 3 production in plants.
The results of our study suggest that the constitutive expression of a heterologous and highly active InsP 5-ptase in tobacco cells has created a "drain" for InsP 3 . The metabolic consequence of the elevated InsP 3 hydrolysis could be that the transgenic cells are in a continuous state of attempting to replenish a pool of PtdInsP 2 through activation of the plasma membrane PtdInsP 5 kinase. Further work will be needed to characterize the altered pools of PtdInsP 2 at a subcellular level and evaluate the impact of these changes on downstream physiology.
MATERIALS AND METHODS
Plant Materials
Tobacco (Nicotiana tabacum) tissue culture cells (NT1 cells) were maintained in 50 mL of liquid culture medium (1ϫ Murashige and Skoog salts
Suc [pH 5.7] ) at 28°C with shaking at 125 rpm, in darkness. Cells were subcultured weekly with a 6% (v/v) inoculum.
Monitoring Cell Growth and Microscopy
For monitoring cell growth over the culture cycle, three replicate 5-mL cultures were harvested daily and the fresh weight was recorded. At 2, 4, and 6 d after transfer, cell samples were stained with 0.01% (w/v) fluorescein diacetate in acetone (Widholm, 1972) and cell viability was determined by fluorescence microscopy, using a Axiovert 100 TV microscope (Zeiss, Jena, Germany) coupled to a cooled CCD camera. Images were resolved using a 25ϫ 2EIBS plan-neofluar lens. Fluorescence excitation was by a super-high pressure mercury lamp in front of a 470-Ϯ 40-nm barrier filter. Fluorescence emission was filtered using a 510-nm dichroic mirror and a 540-Ϯ 50-nm filter. Bright-field images were also recorded for each field of view.
Plant Transformation and Selection of Transgenic Lines
The cDNA encoding the human type I InsP 5-ptase (accession no. X77567) was subcloned into the XbaI site of the pKYL71-35S 2 binary vector (Schardl et al., 1987) . The pKYL71-35S 2 vector contains a modified 35S promoter, 3Ј-untranslated region of the pea (Pisum sativum) rbcS E-9 gene, and a plant kanamycin resistance cassette. The coding region of the InsP 5-ptase gene, along with the 5Ј end His tag, was amplified from the bacterial expression vector pQE31 using forward and reverse primers engineered to contain XbaI sites. The orientation of the resulting plasmid, pKYL71-35S 2 -InsP 5-ptase, was verified by restriction enzyme analysis and DNA sequencing.
NT1 cells were transformed using Agrobacterium tumefaciens-mediated gene transfer following the protocol of Persson et al. (2001) 2 . The NT1 cell-A. tumefaciens mix was incubated for 48 h at 28°C and suspended in an equal volume of NT1 culture medium. Approximately 0.5 mL of the resulting cell suspension was plated onto solid NT1 culture medium containing 0.8% (w/v) Phytagar (Gibco BRL), 50 g mL Ϫ1 kanamycin, and 200 g mL Ϫ1 timetin, and excess liquid allowed to dry. Plates were incubated for 14 d at 28°C. For each transformation, 15 independent, kanamycin-resistant microcalli were picked, suspended in 1 mL of NT1 medium containing 50 g mL Ϫ1 kanamycin and 200 g mL Ϫ1 timetin, and incubated for 7 d at 28°C, at 190 rpm, in darkness. Suspension cultures that formed under these conditions were retained and transferred to 4 mL of NT1 culture medium containing 50 g mL Ϫ1 kanamycin and 200 g mL Ϫ1 timetin, and incubated for 7 d as described above. To maintain the lines, cells were subcultured weekly, as described above, in 5 mL of NT1 culture medium containing 50 g mL Ϫ1 kanamycin. To verify transformation and determine if the transgene was expressed, independently, transformed NT1 cell lines were harvested after 4 d of growth and frozen in liquid N 2 . One hundred milligrams of frozen cells was ground and extracted in 100 L of 2ϫ SDS-PAGE sample buffer and the crude lysates were separated by SDS-PAGE. After electrophoresis proteins were electroblotted onto hydrophobic PVDF membranes (Gelman Sciences, Ann Arbor MI) and the blots were probed with a monoclonal antiserum that recognizes the His tag (RGS-His monoclonal antibody, Qiagen). Of 15 transformed lines, 11 showed InsP 5-ptase expression, whereas no protein was detected in wild type and vector-only controls. Three of the cultures that showed high InsP 5-ptase expression were selected for further analysis and maintained weekly by subculturing in 50 mL of NT1 culture medium containing 50 g mL Ϫ1 kanamycin.
RNA Extraction and RNA Gel-Blot Analysis
RNA was isolated from 4-d old-NT1 cultures (approximately 0.2 g fresh weight) using a plant RNeasy kit (Qiagen) according to the manufacturer's instructions. Total RNA (5 g) was electrophoresed on a 1% (w/v) agarose gel in formaldehyde (Perera and Zielinski, 1992 ) and transferred to MagnaGraph nylon transfer membrane (Osmonics Lab Products, Minnetonka, MN) overnight in 20ϫ SSPE (0.2 m NaH 2 PO 4 ⅐water/NaOH [pH 7.4], 20 mm Na 2 EDTA⅐2H 2 O, and 2.98 m NaCl). Blots were prehybridized for 3 to 4 h at 44°C and hybridized at the same temperature for 16 h. Prehybridization and hybridization was carried out in 50% (v/v) formamide, 5ϫ SSPE, 5ϫ Denhardt's solution (100ϫ Denhardt's solution is 2% [w/v] each of bovine serum albumin [BSA] , polyvinylpyrrolidone, and Ficoll 400), 100 g mL Ϫ1 denatured calf thymus DNA, and 0.5% (w/v) SDS. The probe was prepared by oligolabeling of the InsP 5-ptase cDNA with ␣-[ 32 P] dCTP and random hexamer primers using DNA polymerase Klenow fragment (Promega, Madison, WI) were washed twice at room temperature in 2ϫ SSPE/0.2% (w/v) SDS, followed by washes in 1ϫ SSPE/0.1% (w/v) SDS at room temperature and hybridization temperature. The final washes were in 0.1ϫ SSPE/0.1% (w/v) SDS at 44°C and 55°C. Hybridization was visualized by autoradiography.
Preparation of Total Protein Lysates, Microsomes, and Plasma Membranes
NT1 cells were harvested at d 4 by filtration and immediately homogenized in 3 volumes of cold buffer (200 mm Suc, 30 mm Tris/HCl [pH 7.2], 3 mm EGTA, 1 mm MgCl 2 , 1 mm dithiothreitol, and 1 mm phenylmethylsulfonyl fluoride) in a glass Dounce homogenizer with 1% (w/v) polyvinylpolypyrrolidone to facilitate grinding. The crude extract was clarified by centrifugation at 5,000g for 10 min at 4°C. The supernatant was used as total cell lysate or fractionated further (40,000g, for 60 min, at 4°C) to yield microsomal and soluble protein fractions. The microsomal pellet was washed in buffer (30 mm Tris/HCl [pH 7.2] and 15 mm MgCl 2 ), centrifuged at 40,000g for 30 min at 4°C, and the final pellet was resuspended in the same buffer. Plasma membrane-enriched fractions were prepared from microsomes by aqueous two-phase partitioning as described previously (Perera et al., 1999) . For enzyme assays, membrane fractions were placed on ice and assayed immediately. Protein concentrations were estimated using the Bio-Rad protein assay reagent with BSA as a standard.
Electrophoresis and Immunoblotting
Protein samples were boiled in SDS-PAGE sample buffer for 5 min, centrifuged briefly, and separated by electrophoresis by SDS-PAGE on 10% (w/v) polyacrylamide gels. For immunoblotting, proteins were transferred to PVDF membrane by electroblotting in 1ϫ CAPS buffer containing 10% (v/v) MeOH for 1 h at 50 V. Membranes were blocked for 1 h in 3% (w/v) BSA in Tris-buffered saline buffer followed by two washes in Tris-buffered saline with 0.2% (v/v) Tween (TBST). Blots were incubated with the primary antibody (RGS-His; 1:1,500 [v/v] dilution in TBST) for 1 h followed by three washes in TBST. The blots were then incubated in the secondary antibody (horseradish peroxidase-conjugated anti-mouse; 1:20,000 [v/v] in TBST) for 1 h followed by three washes in TBST. Immunoreactivity was visualized by incubating the blot in SuperSignal West Pico Chemiluminescent substrate (Pierce, Rockford, IL) and exposure to x-ray film. After chemiluminescence detection, total protein was visualized by staining the blots with Amido black (Sigma, St. Louis).
Assay for InsP 5-ptase
Equal amounts of protein extracts (total lysate, microsomal, or soluble fractions) were incubated with commercial InsP 3 (30 pmol) in 100 L of volume containing 3 mm MgCl 2 for 10 min at room temperature. Reactions were stopped by the addition of 5 mm EDTA. The InsP 3 remaining in each reaction after incubation was quantified using the assay described below. The amount of non-hydrolyzed InsP 3 remaining after incubation in the wild-type microsomal fraction was set to 100%. InsP 3 hydrolyzed by each fraction relative to the wild-type microsomal control (100-InsP 3 remaining in each sample) was plotted as a measure of InsP 5-ptase activity.
InsP 3 Assays and PtdInsP 2 Mass Measurements
Cells were harvested by filtration and immediately frozen in liquid N 2 and ground to a fine powder and precipitated with cold 20% (v/v) perchloric acid. For InsP 3 measurements, approximately 0.2 to 0.3 g (fresh weight) was used/assay. For the PtdInsP 2 measurements, 1.5 to 2 g (fresh weight) was used/assay. InsP 3 assays were carried out using the TRK1000 InsP 3 assay kit (Amersham Pharmacia Biotech, Piscataway, NJ) as previously described (Perera et al., 1999 (Perera et al., , 2001 , and PtdInsP 2 mass measurements were carried out as described (Heilmann et al., 1999 (Heilmann et al., , 2001 ).
PtdInsP 5 Kinase Assays
In vitro lipid kinase assays were carried out using 30 g of microsomal protein or 1 to 2 g of plasma membrane protein. The standard assay contained 50 mm Tris/HCl (pH 7.5), 10 mm MgCl 2 , 1 mm sodium molybdate, 50 m ␥[ 32 P] ATP (10 Ci reaction Ϫ1 ), and 100 m PtdIns4P (Avanti Polar Lipids, Alabaster, AL). Reactions were carried out at room temperature for 15 min in a total volume of 50 L. After incubation, phospholipids were extracted by using an acidic CHCl 3 /MeOH extraction method (Cho and Boss, 1995 
PLC Assays
The PLC activity of plasma membrane fractions was monitored as described by Hirayama et al. (1995) with some modifications. Samples were incubated at room temperature for 10 min in buffer containing 50 mm Tris/HCl (pH 6.4), and 160 m [ 3 H] PtdIns(4,5)P 2 (approximately 5,000 dpm nmol Ϫ1 ), with 10 to 20 m Ca 2ϩ (as described by Cho et al., 1993) in a final volume of 50 L. Reactions were stopped by adding 2 mL of cold CHCl 3 :
MeOH (2:1 [v/v]), followed by 0.5 mL of 1 n HCl. Samples were vortexed and centrifuged to separate phases and approximately 0.9 mL of the aqueous phase was removed and the radioactivity measured by liquid scintillation counting.
Mastoparan Stimulation
Synthetic peptides of mastoparan (Mas-7) and the inactive analog (Mas-17) were synthesized by the Microprotein Chemistry Facility of the Program of Molecular Biology and Biotechnology (University of North Carolina, Chapel Hill). Stock solutions (1.5 mm) of Mas-7 and Mas-17 were made up in water. Cell cultures (5 mL) were maintained on a shaker for the duration of the experiment. Mas-7 or Mas-17 were added to a final concentration of 5 m and at the indicated times, samples were harvested by filtration and immediately frozen in liquid N 2 . InsP 3 was analyzed as described above.
In Vivo Labeling of Cells
In vivo labeling was carried out with cells growing at the same rate with equivalent fresh weights. For 24-h labeling studies, 5 mL of cultures of 3-d-old wild-type and transgenic cells (approximately 0.1g cells mL Ϫ1 ) were labeled with 20 Ci myo[2-
3 H] inositol (20 Ci mmol Ϫ1 ). After 24 h, cells were harvested by filtration, ground in liquid N 2 , and incubated with cold 5% (v/v) perchloric acid containing 1 mg mL Ϫ1 phytate carrier for 15 min on ice. The pellet and supernatant were separated by centrifugation, the pellet was washed two times with cold water, and the lipids extracted as described previously (Cho and Boss, 1995) . For short-term labeling, 4-d-old cells were harvested by filtration, weighed, and resuspended in conditioned medium (0.2g mL Ϫ1 ). After a 30-min recovery period, cells were labeled with [ 32 P] Pi (70-80 Ci mL Ϫ1 ). One-milliliter aliquots were removed at the indicated time points and added immediately to 1 mL of cold 20% (v/v) perchloric acid and incubated on ice for approximately 20 min. The pellet was washed two times with cold water and lipids were extracted, separated by TLC, and quantified as described above.
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